Navigation Links
Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting

gnificant, in favor of the satraplatin arm.

PFS data as observed by the clinical site investigators were also presented today. Compared to the PFS data previously reported, these progression events were not adjudicated by the blinded independent review committee. The hazard ratio for PFS for the intent-to-treat population per investigator observation was 0.58 (95% CI: 0.50-0.67, p = 0.000000000002). Median time to progression was 16.0 weeks for the satraplatin arm versus 6.0 weeks for control. The hazard ratio for PFS for the intent-to-treat population treated with prior Taxotere(R) (docetaxel) per investigator observation was 0.52 (95% CI: 0.42-0.65, p=0.000000002), with a median time to progression of 15.3 weeks for the satraplatin arm compared to 5.6 weeks for control. These data are consistent with the PFS outcomes as adjudicated by the blinded independent review committee.

Safety findings in the SPARC trial were consistent with previous clinical studies involving satraplatin. Myelosuppression (decrease in the production of blood cells by the bone marrow) was the most common adverse reaction associated with satraplatin therapy. Twenty-one percent of patients in the satraplatin arm experienced grade 3 or 4 thrombocytopenia; 14% had grade 3 or 4 leucopenia and 21% had grade 3 or 4 neutropenia. Gastrointestinal disorders were the most frequent non-hematological adverse events (occurring in 57.9% of the patients receiving satraplatin). Eight percent of patients in the satraplatin arm experienced grade 3 or 4 gastrointestinal toxicities, including nausea (1.3%), vomiting (1.6%), diarrhea (2.1%) and constipation (2.1%). Additionally, 5% or less of patients in the satraplatin arm experienced grade 3 or 4 fatigue (1.7%), grade 3 or 4 infections (4.0%) and pulmonary/respiratory grade 3 or 4 toxicities (3.0%).

Preliminary data from Phase 2 trial evaluating satraplatin plus Taxol in non-small cell lung cancer also published in ASCO educational book


'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139 Presented at EULAR
4. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
5. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
6. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
7. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Post Your Comments:
(Date:11/21/2014)... N.J. , Nov. 21, 2014  PTC Therapeutics, Inc. ... the 2014 Legend of Technology Award for Vision, Innovation, and ... Ph.D., Chief Executive Officer. This award recognizes an individual who ... New Jersey for several decades. ... Technology Award," stated Stuart Peltz , Ph.D., CEO of ...
(Date:11/21/2014)... IRVINE, Calif. , Nov. 20, 2014  Edwards ... leader in the science of heart valves and hemodynamic ... corporate giving in 2014 to support a strong launch ... Heartbeat Matters , and to improve the global communities ... In 2014, Edwards, global corporate giving will exceed $8 ...
(Date:11/21/2014)... , Nov. 20, 2014 /CNW Telbec/ - KLOX ... announce the following appointments: Todd ... in the newly created role of Chief Commercial Officer, ... system using topical photoconverter gel for the treatment of ... and traumatic wounds, recently approved in Europe ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2KLOX Technologies announces executive appointments 2KLOX Technologies announces executive appointments 3KLOX Technologies announces executive appointments 4
... , , HOUSTON , ... 16-year-old Francesco "Frank" De Santiago. On January 29 , ... transplant operation at Texas Children,s Heart Center . De ... child ever discharged from a pediatric hospital with an implanted ...
... , , KINGWOOD, Texas , Feb. ... announced today that the company has formally offered to purchase ... on selling in the chronic pain management medical sector. The ... not be identified until IMAI has a signed letter of ...
Cached Medicine Technology:Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 2Texas Children's Hospital Discharges History-Making Teen Patient Again; This Time With a Transplanted Heart Replacing Mechanical Device 3International Merchant Advisors, Inc. Offers to Invest in Pharmaceutical Chain 2
(Date:11/23/2014)... 23, 2014 Wright & Schulte LLC ... Ohio and West Virginia residents who allege that they ... disorders due to drinking C8 contaminated water released ... Virginia. According to the C8 complaints, the plaintiffs were ... or lived in at least one of the six ...
(Date:11/22/2014)... November 23, 2014 Cancer researchers in ... connection between intercellular communication tunnels and the growth and ... full story on the Surviving Mesothelioma website. ... the University of Minnesota have just released their study ... and materials between cells. They found that mesothelioma ...
(Date:11/22/2014)... BambooFlooringChina.com is a famous brand in ... its new collection of bamboo mats ; the new ... off. , According to the sales manager of ... it a highly renewable resource. Their bamboo mats are 100% ... which comes from natural bamboo with caramel bamboo strips. ...
(Date:11/22/2014)... (PRWEB) November 22, 2014 In order to ... new promotion of cocktail party dresses. The business knows that ... in social occasions. , Now, the party dresses ... to 70% off. As the leading company in fashion industry, ... favorite outfit for every customer. So it always raises the ...
(Date:11/22/2014)... SATURDAY, Nov. 22, 2014 (HealthDay News) -- The wide ... can pose a threat for people with food allergies, ... there are so many types of food allergies that ... over the holidays," Dr. Guha Krishnaswamy, director of allergy ... said in a hospital news release. "If you ...
Breaking Medicine News(10 mins):Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 2Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 3Health News:40 C8 Lawsuit Claims Filed By Wright & Schulte LLC Alleged Serious Illness Due To C8 Contaminated Water In Ohio And West Virginia 4Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:'Tis the Season of Challenges for Those With Food Allergies 2
... Remain to Vote on the Proposed Merger, SOUTH SAN ... Dear VaxGen Stockholder, March 28th marks the date ... stockholder vote on the proposed VaxGen-Raven,merger. Your vote is important. ... votes cast in person or by proxy at the VaxGen ...
... March 20 Arthur J. Gallagher &,Co. ... Solutions, LLC,headquartered in Fort Washington, Pennsylvania. Terms ... in 2002, Healthcare Risk Solutions, LLC is ... insurance,products, associated risk mitigation consulting services and ...
... haze, scientists say , , THURSDAY, March 20 (HealthDay News) ... an important contributor to smog. , This chemical reaction ... dioxide (NO2) in "excited" states -- was long assumed ... University of California, San Diego, conclude that it,s actually ...
... Peake: Health Care Closer for Veterans, WASHINGTON, March ... access to world-class health care under,a Department of Veterans ... 2008. Secretary of Veterans Affairs Dr. James B. Peake ... Kentucky,Illinois, Indiana, Oklahoma, Tennessee and Washington., "VA is ...
... a proactive follow-up care program designed to help ... of life, PALO ALTO, Calif., March 20 ... it is offering oncology treatment,centers a way to provide ... quality of life. Varian is teaming with,Cogent Health Solutions ...
... people felt better dispersing gifts than buying things for themselves , , ... buy happiness, at least when you spend it on others. ... 21 issue of Science . It found that spending ... , What,s more, most people seemed unaware of this ...
Cached Medicine News:Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 2Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 3Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 4Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 5Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 6Health News:VaxGen Provides Updates and Encourages Stockholders to Vote In Favor of Proposed Merger With Raven 7Health News:Smog's Origins Get Clearer 2Health News:VA to Open 14 New Clinics in Seven States 2Health News:Varian Medical Systems Teams With Cogent Health Solutions to Offer Case Management Software for Cancer Survivorship 2Health News:Varian Medical Systems Teams With Cogent Health Solutions to Offer Case Management Software for Cancer Survivorship 3Health News:Give and Be Happy 2
... the industry strives to control costs, Omega ... for patients and providers by manufacturing high ... compact footprint allows installation in a minimal ... quality for identification of the smallest vessels. ...
... efficiency by reducing errors and eliminating costly ... solution, you can spend less time on ... more time on your patient care. Cardiology ... solution. With over 50,000 installations and a ...
... Manager® is now known as Centricity® Physician ... Office - PM is designed to fit ... an easily adaptable solution as individual as ... of every specialty and size - have ...
... VitalWorks' practice management systems have brought cutting-edge ... bases in the world. Today, Intuition PM ... in a friendly, intuitive manner. Automate patient ... expedite in-office patient processing through wireless hand-held ...
Medicine Products: